Recovering lost sexual desire usually involves identifying and addressing the specific thing suppressing it, whether that is a medication, a hormonal shift, chronic stress, poor sleep, or a relationship pattern that has gone stale. There is no single fix because there is no single cause. The research points to a mix of biological, psychological, and relational factors that vary dramatically from one woman to another, and the most effective approach is often a combination of changes rather than any one intervention.
What Your Brain Is Actually Doing When Desire Drops
Sexual desire runs on a push-and-pull system in the brain. One set of pathways, driven largely by dopamine, revs up arousal and motivation. Another set, influenced heavily by serotonin, acts as a brake. In women diagnosed with persistently low desire, research suggests the brake side is working overtime: serotonin activity stays too high, which damps down dopamine-driven excitation and keeps arousal from getting off the ground.1The Journal of Sexual Medicine. Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options Neuroimaging studies have confirmed this picture, showing that women with low desire tend to have overactive inhibitory signaling from higher brain regions like the prefrontal cortex, rather than simply lacking excitatory drive.2CNS Drugs. The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder
This matters practically because it reframes the problem. Low desire often is not about something being broken or missing. It is about something getting in the way. Many of the strategies that help, from medication changes to mindfulness practice, work by reducing that inhibitory pressure rather than artificially pumping up arousal.
Medications That Quietly Suppress Libido
If your sex drive vanished around the same time you started a new prescription, the medication is worth scrutinizing. Antidepressants, particularly SSRIs and SNRIs, are among the most common culprits. They raise serotonin levels throughout the brain, which helps with depression and anxiety but simultaneously strengthens the inhibitory brake on sexual desire. Managing this can involve dose reduction, switching to a medication with a lower sexual side-effect profile, adding a counteracting agent, or scheduling sexual activity around peak and trough drug levels.3PubMed Central. Antidepressant-Induced Female Sexual Dysfunction None of these should be done without your prescriber’s involvement, but the point is that options exist beyond simply tolerating the side effect.
Hormonal birth control is another frequent contributor that often flies under the radar. Combined oral contraceptives substantially increase a protein called sex hormone-binding globulin, which latches onto testosterone and makes it unavailable. A systematic review and meta-analysis found that free testosterone dropped by about 61% on average during oral contraceptive use.4PubMed Central. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis Since testosterone plays a role in female desire, that is a meaningful reduction. What makes this more complicated is that the binding-protein levels may stay elevated even after you stop taking the pill. One study found that women who had discontinued oral contraceptives still had significantly higher sex hormone-binding globulin levels compared to women who had never used them, even more than 120 days after stopping.5PubMed. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction If you suspect your birth control is part of the issue, a conversation with your gynecologist about alternatives, including non-hormonal methods or progestin-only options, is a reasonable starting point.
Hormonal Shifts Across Life Stages
Two of the biggest hormonal transitions women face, menopause and the postpartum period, can each take a wrecking ball to desire in ways that feel bewildering if you do not know what is happening underneath.
Menopause and Perimenopause
Declining estrogen and androgen levels during the menopause transition affect desire, arousal, lubrication, and the physical comfort of sex itself. Vaginal atrophy, the thinning and drying of vaginal tissue caused by estrogen loss, is a major contributor to postmenopausal sexual problems.6The Journal of Sexual Medicine. Practical Aspects in the Management of Vaginal Atrophy and Sexual Dysfunction in Perimenopausal and Postmenopausal Women A study of menopausal women found that nearly 40% had dysfunction in the desire domain specifically, making it the most commonly affected area of sexual function.7PubMed. Sexual function, menopause and hormone replacement therapy (HRT) Research also shows that both declining estrogen and reduced androgen levels contribute to the problem, with androgen loss playing a particular role in the drop in desire itself.8PubMed. Menopause and sexuality: prevalence of symptoms and impact on quality of life
Hormone replacement therapy can help. Estrogen therapy improves lubrication, reduces pain during sex, and supports orgasm, though its direct effect on desire is more modest unless estrogen levels reach the range typically seen around ovulation.9PubMed Central. Increasing women’s sexual desire: The comparative effectiveness of estrogens and androgens For desire specifically, testosterone has the more robust evidence. Multiple large trials in postmenopausal women found that a testosterone patch significantly increased satisfying sexual episodes, desire scores, and decreased personal distress compared to placebo.10PubMed. Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen 11Menopause. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study In surgically menopausal women receiving estrogen therapy, the combination with testosterone boosted total satisfying sexual activity by roughly 50 to 75% over placebo.12The Journal of Sexual Medicine. Testosterone Treatment for Hypoactive Sexual Desire Disorder in Postmenopausal Women The main side effect at higher doses is unwanted hair growth. Testosterone therapy for women is not yet widely approved worldwide, so accessing it typically requires a specialist willing to prescribe off-label or compound formulations.
Postpartum and Breastfeeding
The postpartum period brings its own hormonal reality. During breastfeeding, prolactin stays elevated to support milk production, and that same prolactin suppresses the hormonal axis that drives estrogen production. The result is a temporary state of low estrogen that causes vaginal dryness, discomfort during sex, and reduced desire. Studies estimate that 60 to 80% of breastfeeding women experience some degree of sexual dysfunction, including lowered libido.13PubMed Central. Sexual function in breastfeeding women: a systematic review Researchers have recently proposed the term “genitourinary syndrome of lactation” to describe this cluster of vulvovaginal, urinary, and sexual symptoms tied specifically to the low-estrogen environment of breastfeeding.14PubMed. Genitourinary syndrome of lactation: An underrecognized postpartum condition affecting women’s vulvovaginal, urinary and sexual health This is not a permanent state. Desire typically returns as breastfeeding tapers and hormonal levels normalize, though fatigue, body changes, and the demands of caring for a newborn extend the timeline for many women. In the meantime, vaginal moisturizers and lubricants can address the physical discomfort that often compounds the loss of desire.
Stress, Sleep, and Their Shared Effect on Desire
Chronic stress does not simply make you too tired for sex. It physically interferes with arousal. In one study, women reporting high chronic stress showed lower genital arousal responses to erotic stimuli and higher cortisol levels. The strongest predictor of their reduced arousal was mental distraction: their brains were too busy processing stressors to engage with sexual cues.15The Journal of Sexual Medicine. Chronic Stress and Sexual Function in Women Separate research found that women with persistently low desire showed markers of a disrupted stress-hormone system, including flatter daily cortisol rhythms and lower morning levels of the hormone DHEA, which is a precursor to both testosterone and estrogen.16PubMed Central. Dehydroepiandrosterone and cortisol as markers of HPA axis dysregulation in women with low sexual desire
Sleep quality is tangled up with both stress and desire. Women with sleep disorders like insomnia and sleep apnea have significantly higher odds of low desire and other sexual difficulties compared to women without them.17PubMed. Sleep Disorders Are Associated with Female Sexual Desire and Genital Response – A U.S. Claims Database Analysis A day-by-day tracking study found that each additional hour of sleep on a given night predicted a meaningful increase in sexual desire the following day.18PubMed. The impact of sleep on female sexual response and behavior: a pilot study Broader surveys confirm the connection: women with sexual dysfunction show higher rates of disrupted sleep quality than women without.19PubMed Central. Association between sexual function in women and sleep quality Improving sleep is not usually framed as a sexual health intervention, but the data suggests it functions as one. Addressing sleep apnea, treating insomnia, or simply protecting a consistent bedtime may have downstream effects on desire that you would not predict without seeing the research.
Mindfulness and Cognitive Behavioral Therapy
If the brain’s inhibitory system is what holds desire back, then psychological interventions that reduce that mental interference can be genuinely therapeutic. Mindfulness-based therapy has the strongest evidence here. A controlled trial found that group mindfulness therapy significantly improved sexual desire, arousal, lubrication, and overall sexual satisfaction in women with low desire, and that increases in mindfulness and reductions in depressive symptoms predicted the improvements in desire.20PubMed. Group mindfulness-based therapy significantly improves sexual desire in women Cognitive behavioral therapy has shown similar benefits, and studies comparing the two found that both led to increased desire, better communication, and greater self-acceptance, though women described the subjective experience differently depending on which approach they used.21PubMed. Subjective effects and perceived mechanisms of change of cognitive behavioral and mindfulness-based online interventions for low sexual desire in women
The core idea behind mindfulness for desire is learning to notice sexual cues, physical sensations, and your own responses without immediately judging them or drifting into worried thinking about performance, body image, or whether you are “normal.” That kind of mental chatter is exactly the top-down inhibition the neuroscience points to. You do not need to join a formal therapy group to start. Apps and self-guided programs teaching body-scan meditation and present-moment awareness during physical sensations can serve as an entry point, though structured therapy tends to produce more consistent results.
Exercise and Body Image
Physical activity supports sexual function through several routes. Cardiovascular fitness improves blood flow to genital tissue, and research on female athletes found that elite-level athletes had better clitoral blood flow and scored higher on most domains of sexual function compared to sedentary women.22The Journal of Sexual Medicine. The Evaluation of Clitoral Blood Flow and Sexual Function in Elite Female Athletes You do not need to train like an Olympian to benefit. Moderate regular exercise improves mood, reduces stress hormones, and supports better sleep, all of which feed into desire through the pathways discussed above.
Body image deserves its own mention because it acts as a surprisingly powerful gatekeeper for desire. Women who feel dissatisfied with their bodies report lower desire and arousal, and feeling that others evaluate your body negatively predicts the same decrements.23PubMed Central. The Relationship Between Body Image and Domains of Sexual Functioning Among Heterosexual, Emerging Adult Women Body image self-consciousness during sex, the kind of intrusive monitoring where you wonder how you look mid-act, specifically predicts worse arousal and orgasm.23PubMed Central. The Relationship Between Body Image and Domains of Sexual Functioning Among Heterosexual, Emerging Adult Women The relationship holds across age groups. Among middle-aged women, body image showed significant correlations with desire, arousal, orgasm, satisfaction, and pain.24PubMed Central. The Relationship Between Body Image and Sexual Function in Middle-Aged Women On the flip side, women with more positive body image report more sexual activity, more willingness to initiate, and greater comfort with physical vulnerability during sex.25PubMed. Effect of body image and self-image on women’s sexual behaviors
This is one area where exercise, mindfulness, and therapy intersect. Exercise can improve how you feel about your body. Mindfulness reduces the self-conscious monitoring during sex. Cognitive behavioral therapy can challenge the distorted beliefs about your body that fuel avoidance. If body image feels like a barrier for you, approaching it directly is likely to pay off in the bedroom more than any supplement or hormone.
Relationship Patterns and Responsive Desire
In long-term relationships, a decline in desire is extremely common and not automatically a sign that something is medically wrong. Research shows that while sexual satisfaction and sexual activity decline for both partners as relationship duration increases, desire itself declines specifically in women.26PubMed. Sexual motivation and the duration of partnership This is not inevitable destiny, but it is a well-documented pattern. One study examining sexual boredom and desire found that the different profiles of boredom and desire did not actually vary by how long the relationship had lasted, suggesting that what matters is less about time and more about the quality of the sexual dynamic.27PubMed. Sexual boredom and sexual desire in long-term relationships: a latent profile analysis
It also helps to understand how desire works in many women. The classic model assumes desire is spontaneous: you feel turned on, then you seek sex. But research on women in long-term relationships led to a different model, one where desire is often responsive rather than spontaneous. In this model, a woman may not feel desire before engaging with a sexual cue or context, but desire builds in response to arousal once things get started.28PubMed. The female sexual response: a different model If you are waiting to feel spontaneously turned on before initiating or agreeing to sex, and that feeling never arrives, you may be measuring yourself against a model that does not actually describe how your desire works. Being open to sexual engagement without pre-existing desire, provided you are willing and the context feels safe, is not “forcing it.” For many women, it is simply how desire functions.
FDA-Approved Medications for Low Desire
Two medications are specifically approved in the United States for treating low desire in premenopausal women.
Flibanserin (sold as Addyi) is a daily oral pill that adjusts the balance between serotonin and dopamine in the brain, essentially loosening the serotonin-driven brake on arousal. It has been shown to improve desire, but it comes with a side-effect profile that has kept it controversial: dizziness, sleepiness, nausea, and dangerous drops in blood pressure if combined with alcohol.29PubMed Central. Flibanserin: A controversial drug for female hypoactive sexual desire disorder The benefit for many women is modest enough that the trade-off is not clearly worth it, and you have to take it every night regardless of whether you plan to have sex.
Bremelanotide (Vyleesi) takes a different approach. It is a self-administered injection given about 45 minutes before anticipated sexual activity and works by activating melanocortin receptors in the brain, triggering excitatory pathways involved in sexual response.30PubMed. Bremelanotide: First Approval Clinical trials found significant improvements in desire and significant decreases in distress related to low desire, though the overall clinical benefit has been described as modest.31PubMed. Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder The most common side effect is nausea, which affected roughly 40% of trial participants.31PubMed. Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder The on-demand dosing is appealing compared to a daily pill, but the injection format and nausea rate put some women off.
Neither medication is currently approved for postmenopausal women, which leaves testosterone as the primary pharmacological option for that group.
Complementary Approaches
If you are dealing with antidepressant-related desire problems specifically and want to try something alongside (not instead of) your prescriber’s guidance, maca root has some preliminary evidence behind it. A controlled trial in women on SSRIs found that the higher dose of maca (3 grams per day) led to a significant improvement in sexual function scores and libido, while a lower dose did not.32PubMed Central. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction A separate placebo-controlled trial in the same population found remission rates on sexual-function scales trending higher in the maca group, though the differences were not large.33PubMed Central. A Double-Blind Placebo-Controlled Trial of Maca Root as Treatment for Antidepressant-Induced Sexual Dysfunction in Women The evidence is encouraging enough to be worth knowing about, but these were small studies and maca is not a reliable standalone treatment.
Cannabis use before sex is another area where survey data and preliminary research exist. In one study, roughly 60% of women who used marijuana before sex reported increased sex drive, and after adjusting for other factors, frequent marijuana use was associated with about twice the odds of reporting satisfactory orgasms.34PubMed Central. The Relationship between Marijuana Use Prior to Sex and Sexual Function in Women The exact mechanism is unclear, though the endocannabinoid system has been linked to sexual arousal.35PubMed Central. Assessment of the Association of Cannabis on Female Sexual Function With the Female Sexual Function Index This is observational data with all the usual caveats: women who choose to use cannabis before sex may differ from those who do not in ways the studies cannot fully account for. It also depends on local legality and your personal tolerance.
Medical Conditions Worth Ruling Out
Before attributing low desire entirely to stress or relationship factors, a couple of medical conditions deserve a look, particularly if your desire change was sudden or accompanied by other symptoms.
Thyroid disorders are common in women and directly affect sexual function. Both an underactive and overactive thyroid can impair desire, arousal, lubrication, and orgasm. The estimated prevalence of sexual dysfunction in women with thyroid disease ranges from roughly 22 to 60% depending on the type of thyroid condition.36Sexual Medicine Reviews. The Impact of Thyroid Disease on Sexual Dysfunction in Men and Women Thyroid disorders can also raise prolactin levels, which in turn suppress the hormonal signals that drive ovulation and sex-hormone production, adding another layer of disruption to desire.37PubMed Central. Systematic review of the association between thyroid disorders and hyperprolactinemia A simple blood test can screen for thyroid problems, and treatment with thyroid medication often improves sexual function alongside other symptoms.
Pelvic floor dysfunction is another underappreciated contributor. An overactive pelvic floor, where the muscles are chronically tense rather than weak, can cause pain during sex and feed into a cycle of avoidance that erodes desire over time. Women with overactive pelvic floors report less sexual desire, arousal, and satisfaction, along with more difficulty reaching orgasm and more negative attitudes toward sex in general.38Sexual Medicine Reviews. “The Overactive Pelvic Floor (OPF) and Sexual Dysfunction” Part 1: Pathophysiology of OPF and its Impact on the Sexual Response Pelvic floor physical therapy can address this, but it requires a clinician who understands that the problem is tension and guarding, not weakness. The standard advice to “do more Kegels” can actually make an overactive pelvic floor worse.